Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Shares Outstanding (Diluted Average) (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Shares Outstanding (Diluted Average) over the past 16 years, most recently at $34.8 million for Q2 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $34.8 million for Q2 2025, down 5.02% from a year ago — trailing twelve months through May 2025 was $34.8 million (down 5.02% YoY), and the annual figure for FY2025 was $34.8 million, down 5.02%.
  • Shares Outstanding (Diluted Average) for Q2 2025 was $34.8 million at Lifecore Biomedical, Inc. \De\, down from $37.0 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for LFCR hit a ceiling of $37.0 million in Q1 2025 and a floor of $29.3 million in Q2 2021.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $30.1 million (2023), compared with a mean of $31.7 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): increased 22.94% in 2023 and later dropped 10.41% in 2024.
  • Lifecore Biomedical, Inc. \De\'s Shares Outstanding (Diluted Average) stood at $29.5 million in 2021, then grew by 0.45% to $29.6 million in 2022, then increased by 22.94% to $36.4 million in 2023, then decreased by 10.41% to $32.6 million in 2024, then rose by 6.77% to $34.8 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $34.8 million (Q2 2025), $37.0 million (Q1 2025), and $32.6 million (Q4 2024) per Business Quant data.